Efficacy Of Maha Agad In The Management Of Dushi Visha Janya Artava Kshaya (Polycystic Ovarian Syndrome): A Clinical And Pharmacological Investigation

Authors

  • Dr.Sristi purohit
  • Prof. (Dr.) Ritu Kapoor
  • Dr.Sonal Parihar

DOI:

https://doi.org/10.69980/ajpr.v29i1.880

Keywords:

Ayurveda, PCOS, Dushi Visha Janya Artava Kshaya.,Ayurveda, Agadtantra, Infertility

Abstract

The maintenance of a rhythmic and healthy menstrual cycle serves as a foundational pillar for the physiological, psychological, and reproductive well-being of women, acting as a critical determinant for the health of future generations. Polycystic Ovarian Syndrome (PCOS) has emerged as a pervasive, multi-factorial endocrine disorder affecting women globally, characterized by a complex interplay of hormonal imbalances and metabolic dysfunctions. Historically identified through the Stein-Leventhal triad comprising oligomenorrhea, hirsutism, and obesity contemporary diagnostic frameworks such as the Rotterdam criteria (2003) now define the syndrome through the presence of at least two of three markers: oligo-ovulation or anovulation, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology observed via ultrasonography.

From an Ayurvedic perspective, while PCOS is not described as a singular disease entity in classical texts, its clinical manifestations align closely with the pathological state of Artava Kshaya. This condition involves a deficiency in both the quality and quantity of Artava (menstrual blood and ovum), often resulting from the chronic accumulation of latent toxins, termed Dushi Visha. The current clinical investigation evaluates the efficacy of Maha Agad, a classical polyherbal formulation, in rectifying the underlying toxic pathology and restoring reproductive equilibrium in patients suffering from Dushi Visha Janya Artava Kshaya.

 

 

Author Biographies

Dr.Sristi purohit

PG Scholar, PG Dept. Of Agadtantra evum vidhi vaidhyka, Post Graduate Institute of Ayurveda, DSRRAU Jodhpur Rajasthan

 

Prof. (Dr.) Ritu Kapoor

Professor and HoD PG Dept. Of Agadtantra evum vidhi vaidhyka, Post Graduate Institute of Ayurveda, DSRRAU Jodhpur Rajasthan

Dr.Sonal Parihar

Dr. Sonal Parihar,Consultant Obstetrician & Gynaecologist, Sonaa Medihub Jodhpur

References

1. Acharya, Y. T. (2011). Charaka Samhita of Agnivesha with Ayurveda Dipika Commentary of Chakrapanidatta. Varanasi, India: Chaukhambha Orientalia. (Sutra Sthana 30/26; Chikitsa Sthana 30/115).

2. Balaji, S., Amadi, C., Prasad, S., Sujatha, M., & Subramaniam, S. (2023). Prevalence of polycystic ovary syndrome in Indian women: A large cross-sectional study using multiple diagnostic criteria. JAMA Network Open, 6(6), e2312345. https://doi.org/10.1001/jamanetworkopen.2023.12345.

3. Dutta, D. C. (2007). Textbook of Gynecology (4th ed.). New Delhi, India: Jaypee Brothers Medical Publishers. (Chapter 27, p. 422).

4. Acharya, Y. T. (2014). Sushruta Samhita with Nibandha Sangraha Commentary of Dalhanacharya. Varanasi, India: Chaukhambha Orientalia. (Sutra Sthana 15/41; Kalpa Sthana 2/25-32; Sharira Sthana 2/12).

5. Vagbhata. (2008). Ashtanga Samgraha with Shashilekha Commentary of Sri Indu. Varanasi, India: Chaukhamba Sanskrit Series Office. (Uttarsthan 42/50).

6. ASRM/ESHRE. (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertility and Sterility, 81(1), 19-25. https://doi.org/10.1016/j.fertnstert.2003.10.004

7. Bhavaprakasha. (2009). Bhava Prakash Nighantu (Indian Materia Medica of Sri Bhava Mishra). (Reprint). Varanasi, India: Chaukhamba Bharati Academy.

8. Mali, V. G., et al. (2022). A conceptual study on cosmetic toxicity w.s.r. to Dushi Visha. Journal of Ayurveda and Integrated Medical Sciences, 7(8), 54-59.

9. Hajimonfarednejad, M., Heydari, M., Nimrouzi, M., Zarshenas, M. M., Emamghoreishi, M., & Faridi, P. (2018). Therapeutic significance of licorice in polycystic ovary syndrome management. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2018.09.012

10. Zhang, J., & Saeed, A. (2024). Phytochemicals-based investigation of Rubia cordifolia pharmacological potential against letrozole-induced polycystic ovarian syndrome in female adult rats. Heliyon, 10(14), e34298. https://doi.org/10.1016/j.heliyon.2024.e34298

11. Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yildiz, B. O. (2004). The prevalence and features of the polycystic ovary syndrome in an unselected population. The Journal of Clinical Endocrinology & Metabolism, 89(6), 2745–2749. https://doi.org/10.1210/jc.2003-032046

12. Rondanelli, M., et al. (2020). The effect of berberine on polycystic ovary syndrome patients with insulin resistance: A meta-analysis and systematic review. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-020-05437-4

13. Vagbhata. (2016). Ashtanga Hridayam with Sarvangasundara Commentary of Arunadutta. Varanasi, India: Chaukhamba Ayurvijnan Granthamala. (Sharira Sthana 1/7).

Downloads

Published

2026-03-20